4/14
08:00 am
imdx
Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay
High
Report
Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay
3/29
09:28 pm
imdx
How The Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Funding And FDA Catalyst [Yahoo! Finance]
High
Report
How The Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Funding And FDA Catalyst [Yahoo! Finance]
3/26
08:07 pm
imdx
Insight Molecular Diagnostics Inc. (IMDX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Insight Molecular Diagnostics Inc. (IMDX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/26
04:39 pm
imdx
IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results [Yahoo! Finance]
High
Report
IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results [Yahoo! Finance]
3/26
04:05 pm
imdx
IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results
High
Report
IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results
3/26
03:31 am
imdx
Insight Molecular Diagnostics Inc. Q4 2025 Earnings Preview [Seeking Alpha]
Medium
Report
Insight Molecular Diagnostics Inc. Q4 2025 Earnings Preview [Seeking Alpha]
3/20
08:29 am
imdx
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference [Yahoo! Finance]
Medium
Report
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference [Yahoo! Finance]
3/20
08:00 am
imdx
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference
Medium
Report
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference
3/14
08:12 pm
imdx
How Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Capital And GraftAssureDx Milestones [Yahoo! Finance]
Medium
Report
How Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Capital And GraftAssureDx Milestones [Yahoo! Finance]
3/13
08:36 am
imdx
Second Study Affirms Superiority of iMDx GraftAssure Assay's Proprietary dd-cfDNA Combination Model Score [Yahoo! Finance]
Low
Report
Second Study Affirms Superiority of iMDx GraftAssure Assay's Proprietary dd-cfDNA Combination Model Score [Yahoo! Finance]
3/13
08:00 am
imdx
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
Low
Report
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
3/3
08:21 am
imdx
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission [Yahoo! Finance]
Medium
Report
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission [Yahoo! Finance]
3/3
08:00 am
imdx
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
Medium
Report
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
2/27
03:35 pm
imdx
How Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Funding And GraftAssureDx Catalyst [Yahoo! Finance]
Low
Report
How Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Funding And GraftAssureDx Catalyst [Yahoo! Finance]
2/17
02:48 pm
imdx
Oncocyte (NASDAQ:IMDX) had its price target raised by analysts at Lake Street Capital from $8.00 to $12.00. They now have a "buy" rating on the stock.
Low
Report
Oncocyte (NASDAQ:IMDX) had its price target raised by analysts at Lake Street Capital from $8.00 to $12.00. They now have a "buy" rating on the stock.
2/11
08:00 am
imdx
iMDx Announces $26.0 Million Registered Direct Offering
Medium
Report
iMDx Announces $26.0 Million Registered Direct Offering